Embecta Corp

Valuation Analysis

About the Company

Embecta Corp en bref

Embecta Corp (EMBC) is currently trading at 2,71 € with a market capitalization of 161 M €. The trailing P/E ratio stands at 1.65x, with a forward P/E of 1.79x. The 52-week range spans from 2,42 € to 13,57 €; the current price is 80% below the yearly high. Year-over-year revenue growth stands at -14.4%. The net profit margin stands at 10.73%.

💰 Dividende

Embecta Corp pays an annual dividend of 0,40 € per share, representing a yield of 14.79%. The payout ratio stands at 31.75%.

📊 Avis des analystes

2 analystes évaluent Embecta Corp (EMBC) au consensus : None. L'objectif de cours moyen est de 3,49 €, soit un potentiel de +28.62% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 2,62 € à 4,36 €.

Embecta Corp : la thèse d'investissement en détail

Embecta Corp (EMBC) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 61.92%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue is contracting at -14.4% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Short interest sits at 14.88% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The EV/EBITDA multiple of 4.13x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The dividend yield near 14.79% combined with a payout ratio of 31.75% leaves room for further hikes — a track record of consecutive raises is a strong income signal.
• The analyst consensus price target implies 28.62% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (14.88%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Embecta Corp?

Compare top-rated brokers — low fees, trusted providers, fully regulated.